Results 31 to 40 of about 5,721 (196)

Investigation of a Potential Pharmacokinetic Interaction Between Nebivolol and Fluvoxamine in Healthy Volunteers

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2017
Purpose: To investigate whether fluvoxamine coadministration can influence the pharmacokinetic properties of nebivolol and its active hydroxylated metabolite (4-OH-nebivolol) and to assess the consequences of this potential pharmacokinetic interaction ...
Ana-Maria Gheldiu   +10 more
doaj   +1 more source

The pharmacogenetics aspects of nebivolol [PDF]

open access: yes, 2022
Introduction. The pharmacokinetic and pharmacodynamic properties of β-blockers depend on the variation in genes that contribute to a wide variability of the response between patients.
Bacinschi, Georgel
core  

The efficacy of nebivolol on spontaneously hypertensive rats with overactive bladder – an experimental study

open access: yesArchives of Medical Science, 2019
Introduction Overactive bladder (OAB) is a disease that significantly decreases quality of life. Adverse effects of the drugs currently used in OAB treatment limit their use in patients with hypertension. Nebivolol (a β 1 -adrenergic receptor blocker) is
Andrzej F. Wróbel   +4 more
doaj   +1 more source

Effects of Metoprolol and Nebivolol on Exercise Blood Pressure in Patients with Mild Hypertension

open access: yesThe Scientific World Journal, 2013
Objectives. We planned to compare the impact of two beta blockers, metoprolol and nebivolol, on arterial blood pressure during exercise in patients with mild hypertension. Methods.
Huseyin Ugur Yazici   +3 more
doaj   +1 more source

Clinical pharmacokinetics of nebivolol: a systematic review

open access: yes, 2023
Nebivolol is a beta-1 receptor blocker used to treat hypertension, heart failure, erectile dysfunction, vascular disease, and diabetes mellitus.
Nida Hanif (17184896)   +8 more
core   +1 more source

COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS

open access: yesРациональная фармакотерапия в кардиологии, 2016
Beta-blockers are an important part of modern pharmacotherapy in cardiology. The introduction of generics into clinical practice requires clear evidence of bioequivalence to the original drug.Aim.
E. I. Bambysheva   +4 more
doaj   +1 more source

The Impact of a Visualized Steerable Sheath on Radiofrequency Catheter Ablation for First‐Time Atrial Fibrillation Ablation: A Prospective, Randomized, Single‐Blind Study

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background A 3D electroanatomical mapping (3D‐EAM) visualized steerable sheath was designed to improve catheter placement and reduce radiation exposure during ablation, an established treatment for atrial fibrillation (AF). However, prospective randomized data comparing the procedural and clinical outcomes of visualized and non‐visualized ...
Chun‐Kai Chen   +4 more
wiley   +1 more source

Evaluation of Anticonvulsant Action of Nebivolol in Albino Mice

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2023
Background: Epilepsy is a disorder of brain function indicating periodic and unpredictable occurrence of seizures. Hypertension is the main cause of intracerebral hemorrhage which is a triggering factor for development of epilepsy. Nebivolol, a β-blocker
Balaji V   +3 more
doaj   +1 more source

Nebivolol [PDF]

open access: yespharma-kritik, 2000
N ...
openaire   +1 more source

Exploring Cerumen as an Alternative Matrix for Drug Detection and Quantification: Method Development and Application in Clinical Samples

open access: yesDrug Testing and Analysis, EarlyView.
An LC–MS/MS method was developed for the detection of 33 psychoactive medications in cerumen (earwax) and applied to the samples of 60 psychiatric inpatient volunteers. The findings highlighted the utility of cerumen as an innovative biospecimen in clinical toxicological analysis.
Dimitrios Phaedon Kevrekidis   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy